Literature DB >> 10492527

Effect of vitamin E deficiency on rat brain monoamine metabolism.

K Adachi1, M Izumi, T Mitsuma.   

Abstract

We investigated the effects of vitamin E deficiency on the monoamine metabolism in the rat brain. Male Wistar rats fed on the vitamin E deficient diet for 24 weeks were analyzed. At 28 weeks, they showed a reduced growth rate (52% of reduction), muscle atrophy, a motor weakness of hind limbs and disturbance of gait. The concentrations of monoamines, their precursors and metabolites in the brain were simultaneously determined using high performance liquid chromatography (HPLC) coupled with a coulometric detection with electrode array system. In addition, tryptophan hydroxylase activity was measured. The dopamine (p = 0.009) and serotonin (p = 0.04) levels in the brain stem of vitamin E deficient rats were significantly lower than in the controls, whereas their precursors tyrosine (p = 0.0009) and tryptophan (p = 0.0065) levels in the brain stem were significantly higher than in the controls. Moreover, tryptophan hydroxylase activity (p = 0.0005) in the brain stem of vitamin E deficient brains was significantly lower than in the controls. All statistical comparisons were done using non-parametric tests (Mann-Whitney U test). These results suggest that vitamin E deficiency may play a role in the disturbance of monoamine metabolism in rat brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492527     DOI: 10.1023/a:1020937409855

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

1.  Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Authors:  P Férnandez-Calle; J A Molina; F J Jiménez-Jiménez; A Vázquez; M Pondal; P J García-Ruiz; D G Urra; J Domingo; R Codoceo
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

Review 2.  The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.

Authors:  S Fahn
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

4.  Free radicals, lipid peroxidation, and Parkinson's disease.

Authors:  M T Smith; M S Sandy; D Di Monte
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

Review 5.  Antioxidant therapy in Parkinson's disease.

Authors:  J D Grimes; M N Hassan; J Thakar
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

6.  Brain peroxidase and catalase in Parkinson disease.

Authors:  L M Ambani; M H Van Woert; S Murphy
Journal:  Arch Neurol       Date:  1975-02

7.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

8.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.

Authors:  T Nagatsu; K Oka; T Kato
Journal:  J Chromatogr       Date:  1979-07-21

9.  Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T L Perry; V W Yong; S Hansen; K Jones; C Bergeron; J G Foulks; J M Wright
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

10.  Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease.

Authors:  A Kilinç; A S Yalçin; D Yalçin; Y Taga; K Emerk
Journal:  Neurosci Lett       Date:  1988-05-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.